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from the HIV Envelope Glycoprotein
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sionº peptide. The hydrophobic fusion-peptide region*Whitehead Institute for Biomedical Research
of HA is known to insert into target membranes as anCambridge, Massachusetts 02142
early event in the membrane fusion process (Stegmann²Howard Hughes Medical Institute
et al., 1991; Tsurudome et al., 1992). In both gp41 andDepartment of Biology
HA2, the fusion-peptide region begins immediately atMassachusetts Institute of Technology
the new amino terminus that results from proteolyticCambridge, Massachusetts 02142
processing reviews, (Wiley and Skehel, 1987; Hunter and
Swanstrom, 1990; White, 1992). In several viral mem-
brane-fusion proteins, including gp41 and HA2, the re-Summary
gion following the fusion peptide has a high a-helical
propensity and a 4-3 heptad repeat of hydrophobic resi-The envelope glycoprotein of human immunodefi-
dues, a sequence feature characteristic of coiled coilsciency virus type 1 (HIV-1) consists of a complex of
(Chambers et al., 1990; Delwart et al., 1990; Gallaher etgp120 and gp41. gp120 determines viral tropism by
al., 1989). X-ray crystallographic studies of fragmentsbinding to target-cell receptors, while gp41 mediates
of HA2 and the transmembrane (TM) subunit of Moloneyfusion between viraland cellular membranes. Previous
murine leukemia virus (Mo-MLV) demonstrate that thesestudies identified an a-helical domain within gp41
heptad-repeat regions do form coiled coils, in bothcomposed of a trimer of two interacting peptides. The
cases as homotrimers (Bullough et al., 1994; Fass et al.,crystal structure of this complex, composed of the
1996).peptides N36 and C34, is a six-helical bundle. Three
Numerous studies have led to the proposal that thereN36 helices form an interior, parallel coiled-coil trimer,
are native (nonfusogenic) and fusion-active (fusogenic)while three C34 helices pack in an oblique, antiparallel
states of viral membrane fusion proteins. In the nativemanner into highly conserved, hydrophobic grooves
HA1/HA2 influenza complex, for example, part of the hep-on the surface of this trimer. This structure shows
tad-repeat region of HA2 folds as a nonhelical loop (Wil-striking similarity to the low-pH-induced conformation
son et al., 1981) but converts to a coiled coil when ex-of influenza hemagglutinin and likely represents the
posed to low pH (Bullough et al., 1994). Since low pHcore of fusion-active gp41. Avenues for the design/
also activates influenza membrane fusion, this confor-discovery of small-molecule inhibitors of HIV infection
mation of HA is generally regarded to be fusogenic,
are directly suggested by this structure.
and we will refer to it as such. The loop to coiled-coil
transition is the basis of the ªspring-loadedº mechanism
Introduction for activation of membrane fusion (Carr and Kim, 1993).
Extensive conformational changes in the HIV enve-
The surface glycoproteins of enveloped viruses play crit- lope complex are also thought to be involved in the
ical roles in the initial events of viral infection, mediating transition from the native to the fusogenic state. Binding
virion attachment to cells and fusion of the viral and of CD4 to gp120 exposes the V3 loop of gp120, which
cellular membranes. Envelope glycoproteins are also likely interacts with the coreceptors (Choe et al., 1996;
major targets for the anti-viral immune response in in- Trkola et al., 1996; Wu et al., 1996). For some laboratory-
fected hosts. The human immunodeficiency virus type adapted isolates of HIV-1, the conformational changes
1 (HIV-1) envelope glycoprotein consists of two nonco- in gp120 upon CD4 binding are sufficient to cause gp120
valently associated subunits, gp120 and gp41, that are to physically dissociate or ªshedº from the viral surface,
generated by proteolytic cleavage of a precursor poly- leaving the membrane-anchored gp41 subunit behind
peptide, gp160 (review, Luciw, 1996; Freed and Martin, (Moore et al., 1990; Hart et al., 1991). Primary isolates
1995). gp120 directs target-cell recognition and viral of the virus generally do not shed gp120 readily in the
tropism through interaction with the cell-surface recep- presence of CD4 alone, although CD4 binding still in-
tor CD4 and one of several coreceptors that are mem- duces conformational changes in gp120 (Sattentau and
bers of the chemokine receptor family (Broder and Dimi- Moore, 1993; Sattentau et al., 1993; Sullivan et al., 1995;
trov, 1996; D'Souza and Harden, 1996; Wilkinson, 1996). Stamatatos and Cheng-Mayer, 1995). CD4 binding also
The membrane-spanning gp41 subunit then promotes induces conformational changes in gp41, as inferred
fusion of the viral and cellular membranes, a process from changes in antibody binding and sensitivity to lim-
that results in the release of viral contents into the host ited proteolysis (Sattentau and Moore, 1991, 1993).
cell. Moreover, addition of low levels of soluble CD4 en-
The HIV envelope glycoprotein complex shares sev- hances the infectivity of some viral isolates, suggesting
eral features with other viral membrane-fusion proteins, that the gp120/gp41 conformational changes induced
including the hemagglutinin (HA) protein of influenza by CD4 play a role in membrane fusion (Allan et al., 1990;
virus, for which the mechanism of membrane fusion has Sullivan et al., 1995). These conformational changes are
been studied in greater detail (Wiley and Skehel, 1987; thought to expose the hydrophobic, glycine-rich fusion-
Stegmann and Helenius, 1993). For example, HA is pro- peptide region of gp41 that is essential for membrane-
fusion activity.teolytically processed, as is the HIV envelope precursor,
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It has not yet been possible to obtain a detailed struc- temperature (Lu et al., 1995; Blacklow et al., 1995). With
a view toward crystallographic studies, further proteinture for gp41, either alone or in complex with gp120. We
have therefore applied a protein-dissection approach, in dissection experiments were used to define a slightly
smaller subdomain with more favorable thermodynamicwhich key substructures of a protein are identified and
studied (e.g., Oas and Kim, 1988). Protein dissection has properties. These studies (M. Lu and P. S. K., unpub-
lished data) led to the identification of the peptides N36been used successfully to study other viral membrane
fusion proteins (Carr and Kim, 1993; Bullough et al., and C34 (Figure 1). Like the longer peptides, N36 and
C34 form a stable, trimeric complexof heterodimers with1994; Fass and Kim, 1995; Fass et al., 1996). Limited
proteolysis of a fragment corresponding to the ectodo- 100% helix content. Unlike the larger complex, however,
the N36/C34 complex has a reversible thermal unfoldingmain of gp41 generated a stable, soluble complex com-
posed of two peptide fragments denoted N51 and C43 transition (M. Lu and P. S. K., unpublished data). Here
we present the crystal structure of this complex solved(Figure 1) that are derived from the N- and C-terminal
regions of the ectodomain, respectively (Lu et al., 1995). to 2.0 AÊ resolution and discuss the implications of this
structure for HIV viral membrane fusion and its inhibition.The N51 peptide corresponds to the 4-3 hydrophobic
repeat region adjacent to the fusion peptide, while the
C43 peptide is derived from the region prior to the trans- Results
membrane segment (Figure 1).
Interestingly, isolated peptides that overlap, or are
Crystals of N36/C34 were grown by sitting-drop vapor
derived from, the N51 and C43 regions of gp41 can have
diffusion (see Experimental Procedures).An initial model
potent anti-viral activity (Wild et al., 1992, 1994b; Jiang
of the complex was built into an electron density map
et al., 1993). Peptides from the C-terminal region of the
generated by multiwavelength anomalous dispersion
ectodomain have the highest activity. Consistent with
(MAD) analysis (review, Hendrickson, 1991) of an os-
these studies, both N51 and C43 are capable of inhib-
mium-derivatized crystal. Details of data collection and
iting HIV envelope±mediated cell fusion; theC43 peptide
MAD phasing statistics are listed in Table 1. A represen-
exhibits 10-fold greateractivity than N51 (Lu et al., 1995).
tative portion of the solvent-flattened electron density
The inhibitory activity of the C43 peptide, however, is
map used for building the initial model is shown in Figure
markedly reduced when stoichiometric amounts of N51
2. The structure was refined against data to 2.0 AÊ from
are present, suggesting that the C43 peptide inhibits
a native crystal to yield an Rfree of 0.266 and an Rcryst ofmembrane fusion in a dominant-negative manner, by
0.238 (Table 1).
associating with an N51 region within intact gp41 (Lu et
al., 1995). Thus, in addition to providing insights into
the mechanism of membrane fusion, determining the Structure of the N36/C34 Complex
The N36/C34 complex is a six-stranded helical bundlestructural basis for interaction between the N51 and C43
regions could assist anti-viraldrug-development efforts. (Figure 3).The center of this bundle consists of a parallel,
trimeric coiled coil of three N36 helices wrapped in aBiophysical studies showed that the N51 and C43
peptides associate to form a highly thermostable, heli- gradual left-handed superhelix. Three C34 helices wrap
antiparallel to the N36 helices in a left-handed directioncal, trimeric complex of heterodimers, in which the N51
and C43 helices are oriented in an antiparallel manner around the outside of the central coiled-coil trimer. This
arrangement of helices was anticipated on the basis of(Lu et al., 1995). Analogous experiments with the gp41
ectodomain from simian immunodeficiency virus (SIV) sequence analysis and biophysical studies (Lu et al.,
1995; Blacklow et al., 1995). The overall dimensions ofgave almost identical results, indicating that the gp41
core identified in these protein-dissection studies is this complex comprise a cylinder measuring z35 AÊ in
diameter and z55 AÊ in height.conserved among lentiviruses (Blacklow et al., 1995).
On the basis of these results and other considerations, As in other naturally occurring coiled coils (Cohen and
Parry, 1990), the interior residues at the aand d positionswe proposed that the gp41 core consists of an interior
coiled-coil trimer formed by the N51 region, against of the N36 heptad repeat are predominantly hydropho-
bic, although occasional buried polar interactions arewhich three C43 helices pack (Blacklow et al., 1995; Lu
et al., 1995). also present in the central three-stranded coiled coil
(Figure 4). A sequence comparison of HIV-1 (HXB2The thermal denaturation of the N51/C43 complexes
from HIV-1 or SIV gp41 are irreversible, probably as a strain) and SIV (Mac239 strain) gp41 shows that the
residues at these two heptad-repeat positions are highlyresult of aggregation of the unfolded peptides at high
Figure 1. Interacting Peptides Identified in
HIV gp41
A schematic view of gp41 showing important
functional regions, including the 4-3 hy-
drophobic repeat, the fusion peptide (fp), a
disulfide linkage (S-S), and the transmem-
brane region (tm). The ectodomain is drawn
approximately to scale. The peptides identi-
fied by protein dissection are shown above,
along with the sequences of N36 and C34.
The residues are numbered according to their
position in gp160.
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Table 1. Crystallographic and Refinement Statistics
Data Collection
Crystal l (AÊ ) Complete (%) Rsyma (%) Resol. (AÊ )
Native 1.5418 96.5 5.5 2.0
OsO4 l1 1.1398 96.4 4.3 2.7
OsO4 l2 1.1396 96.4 4.3 2.7
OsO4 l3 1.1344 96.8 4.5 2.7
OsO4 l4 1.1406 93.4 4.5 2.7
Phasing Statisticsh (12±2.7 AÊ )
Rdiffc (%) Rcullisd Rcullisd Rcullisd Ph. powere Ph. powere Anom.
Derivative Risob (%) (weighted) Acentric Centric Anom. Acentric Centric Occ.f Occ.f
OsO4 l1 vs. l4 4.4 6.7 0.46 0.53 0.21 2.46 1.53 0.075 2.165
OsO4 l2 vs. l4 6.6 9.3 0.37 0.37 0.22 3.34 2.36 0.132 1.784
OsO4 l3 vs. l4 5.4 7.4 0.42 0.44 0.35 2.94 2.12 0.105 1.005
Refinement Statistics (12±2.0 AÊ )
Number of Reflections rms Deviations
Nonhydrogen
Protein Atoms Waters Working Free Rcrystg Rfreeg Bonds (AÊ ) Angles (8)
596 43 5212 371 (7.12%) 0.238 0.266 0.014 2.742
a Rsym 5 SSj|Ij 2 ,I.| / S|,I.|, where Ij is the recorded intensity of the reflection j and ,I. is the mean recorded intensity over multiple
recordings.
b Riso 5 S||F(li) 6 F(l4)| 2 |F(li)|| / S|F(l4)|, where F(li) is the structure factor at wavelength li and F(l4) is the structure factor at the reference
wavelength l4.
c Rdiff 5 [S|(F2(l4) 2 Fmean) / wF2(l4)| 1 |(F2(l i) 2 Fmean) / wF2(li)|] / [S[(F2(l4) / wF2(l4)) 1 (F2(li) / wF2(l i))]], where Fmean 5 [(F2(l4) / wF2(l4)) 1 (F2(li) / wF2(li))] /
[(1/wF2(l4)) 1 (1/wF2(li))] and wF2(n) 5 [Variance (F2(n))]4F2(n).
d Rcullis 5 S||F(li) 6 F(l4)| 2 |Fh(l i),c||/S|F(li) 6 F(l4)|, where Fh(li),c is the calculated heavy atom structure factor.
e Phase power 5 ,Fh(li). / E, where ,Fh(li). is the root-mean-sqaure heavy atom structure factor and E is the residual lack of closure error.
f Occupancies are values output from MLPHARE.
g Rcryst, free 5 S||Fobs| 2 |Fcalc|| / |Fobs|, where the crystallographic and free R factors are calculated using the working and free reflection sets,
respectively.
h Overall figure of merit (before solvent flattening): 0.89.
conserved (Figure 4). The characteristic ªknobs-into- shown that the isolated N-peptides tend to aggregate
(Blacklow et al., 1995; Lu et al., 1995). Thus, conclusionsholesº packing of coiled coils is utilized, whereby the
residues (knobs) at the a and d layers pack into cavities regarding the oligomerization state of gp41 based on
studies of isolated N-peptides are probably misleading.(holes) between four residues of an adjacent helix (Crick,
1953; O'Shea et al., 1991). Of the three types of knobs- The N36/C34 complex shows a much more highly
charged surface due to acidic residues on the outsideinto-holes packing geometry observed in coiled-coil
structures (Harbury et al., 1993, 1994), the N36 trimer of the C34 helices (Figure 5), explaining the greater solu-
bility of the heterodimeric complex.demonstrates exclusively ªacuteº packing geometry
(data not shown), similar to that found in the crystal
structure of an isoleucine-zipper trimer (Harbury et al., Interactions between the N and C Peptide Helices
Three C34 helices pack obliquely against the outside of1994). This type of packing arrangement in the interior
of the coiled coil is characteristic of trimers because it the N36 coiled-coil trimer in an antiparallel orientation.
These C34 helices interact with N36 mainly through hy-allows b-branched residues (e.g., isoleucine) to pack
favorably at both the a and d positions (Harbury et al., drophobic residues in three grooves on the surface of
the central coiled-coil trimer. Sequence comparisons1994). Trimeric coiled coils, like the N36 trimer (Figure
4), tend to have b-branched residues at both the a and between HIV and SIV gp41 show that the residues lining
these grooves are highly conserved (Figure 6). In con-d positions.
Although complexes of the N and C peptides are trast, the N36 residues flanking the C34 helices arediver-
gent between HIV and SIV (Figure 6).clearly trimeric (Lu et al., 1995; Blacklow et al., 1995)
isolated N peptides corresponding to the 4-3 hydropho- This pattern of sequence conservation is also appar-
ent ona helical wheel representation of three N36helicesbic repeat from gp41 have been reported to form tetra-
mers, leading to conflicting conclusions regarding the and one C34 helix (Figure 4). In this diagram, the residue
positions in C34 are depicted as ellipses to indicate theoligomeric state of gp41 (Rabenstein and Shin, 1995,
1996; Lawless et al., 1996; Shugars et al., 1996). An oblique tilt of the C34 helix relative to the N36 superhelix
and to emphasize that C34 is not part of a coiled coil.electrostatic potential map of the N36 coiled-coil trimer
shows that its surface is largely uncharged (Figure 5). Residues at the e and g positions of the N36 helices lie
on the outside of the central coiled coil and point intoThe grooves that are the sites for C34 interaction are
lined with predominantly hydrophobic residues (see be- the triangular interhelical space between two N36 heli-
ces and a buttressing C34 helix. In general, residues atlow) that would be expected to lead to aggregation upon
exposure to solvent. Indeed, previous studies have positions a and d of C34 pack against residues at the
Cell
266
Figure 3. Overall Views of the N36/C34 Complex
The left panel shows an end-on view of the N36/C34 complex looking
down the three-fold axis of the trimer. The right panel shows a side
view with one N36 and one C34 helix labeled. The amino termini of
the N36 helices (blue) point toward the top of the page, while those
of the C34 helices (purple) point toward the bottom. Diagrams were
prepared using the program MOLSCRIPT (Kraulis, 1991).
cavity is composed of Thr-569, Ile-573, and Leu-576.
Figure 2. Experimental Electron Density Map With the exception of Ile-573 (which is replaced by Thr),
A representativeportion of the initial electron density mapcalculated all the residues forming the cavity are identical between
using experimental structure-factor amplitudes and solvent-flat- HIV-1 and SIV. In addition to these predominately hy-
tened MAD phases is shown with the refined molecular model. The
drophobic interactions within the cavity, Asp-632 of C34map is contoured at 1.5 standard deviations above the mean den-
formsa conservedsalt bridge with Lys-574 of N36 imme-sity. The figure was generated with the program O (Jones and Kjeld-
diately to the left of the cavity.gaard, 1992).
Similarity to the Low-pH-Inducede and g positions of the N36 helices (Figure 4), although
Conformation of HAcontacts at other positions are often observed. Compar-
The N36/C34 complex shows striking structural similar-ing HIV and SIV gp41, no nonconservative changes exist
ity to the low-pH-induced conformation of the influenzaat the e and g positions of the N36 helix, and only two
HA2 subunit (TBHA2) (Bullough et al., 1994) and to thesuch changes occur at the a and d positions of C34. In
TM subunit of Mo-MLV (Fass et al., 1996), each of whichcontrast, 8 of the 9 nonconservative changes in the N36
has been proposed to be a fusogenic conformation.helix occur at the outside f, b, and c positions, while 13
Remarkably, the core of each of the three structuresof the 15 nonconservativechanges in the C34helix occur
contains a three-stranded coiled coil that would be adja-at positions other than a and d. The sequence of the
cent to the amino-terminal fusion peptide (Figure 8). TheN-peptide region of gp41 is among the most highly con-
trimeric coiled coil of gp41 is very similar to that of theserved within the HIV envelope glycoprotein. Our results
Mo-MLV TM, both having a similar superhelical pitchshow that the high sequence conservation in this region
(z175 AÊ ) and a regular 4-3 periodicity. In contrast, theresults from selective pressure on the e and g positions
TBHA2 coiled coil is atypical because it contains twoto retain C34 peptide interactions, as well as pressure
regions with skips in the 4-3 periodicity, resulting in anon the a and d positions to maintain trimeric coiled-coil
underwound superhelix (pitch of 300±400 AÊ ). As in theinteractions.
gp41 core structure, TBHA2 contains three antiparallelEach of the grooves on the surface of the N36 trimer
helices that are packed, with a left-handed tilt, againsthas a particularly deep cavity (Figure 7, left panel). This
the central trimeric coiled coil.cavity is large (z16 AÊ long, z7 AÊ wide, and 5±6 AÊ deep)
and accommodates three hydrophobic residues from
the abutting C34 helix: Ile-635, Trp-631, and Trp-628. Discussion
As depicted in Figure 7 (right panel), the top of the cavity
is lined by Leu-566 of the left N36 helix and Leu-565 of Evidence That the N36/C34 Structure Corresponds
to the Core of the Fusion-Active Conformationthe right N36 helix. Side chains from the left N36 helix
form the left side of the cavity, including residues (top The structure obtained in these studies could, in princi-
ple, correspond to the core of gp41 in either the fuso-to bottom) Val-570, Lys-574 (aliphatic portion), and Gln-
577. The right wall is formed by residues Leu-568, Trp- genic or the native state of the envelope glycoprotein,
or both. Several considerations provide good evidence571, and Gly-572 of the right N36 helix. The floor of the
Crystal Structure of the HIV-1 gp41 Core
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Figure 5. Electrostatic Potential Maps of the Trimer and N36/C34
Complex
An electrostatic potential map (67 kBT/e, where kB 5 Boltzmann's
constant and T 5 absolute temperature) of the N36 trimer (left) and
N36/C34 complex (right). Regions of basic potential are colored
blue, while acidic regions are red. Figure was created with the pro-
gram GRASP (Nicholls et al., 1991).
Figure 4. Helical Wheel Representation of N36 and C34 to thermal denaturation. The N51/C43 complex has an
Three N36 helices and one C34 helix are represented as helical apparent melting temperature of approximately 908C (Lu
wheel projections. The view is from the top of the complex, as in et al., 1995). In contrast, the native state of the HIV
the left panel of Figure 3. The residues at each position are colored
envelope glycoprotein is not particularly stable, as evi-according to their conservation between HIV-1 (HXB2) and SIV
denced by the ease with which gp120 is shed in prepara-(Mac239): red, identity; black, conservative change; green, noncon-
tions of virus particles (Kalyanaraman et al., 1990;servative change. The N36 helices interact through ªknobs-into-
holesº packing interactions at thea and d positions (colored orange). Helseth et al., 1991).
Positions of the N36 and C34 helices that occupy the interhelical Third, mutations in gp41 that abolish infectivity and
space between two N36 helices and a C34 helix are shown in yellow. membrane fusion often map to residues that are ex-
The helical wheel positions in C34 are indicated by ellipses to repre-
pected to stabilize the gp41 core structure determinedsent the oblique orientation of this helix relative to N36. At the top
here. Numerous studies show that mutations in the 4-3of the complex, C34 is slightly tilted toward the left N36 helix, while
hydrophobic repeat region abolish membrane fusion,at the bottom of the complex (indicated by darker shading), it is
slightly tilted toward the right N36 helix. although these mutants tend to have additional defects
(Dubay et al., 1992; Chen et al., 1993; Chen, 1994; Wild et
al., 1994a; Poumbourios et al., 1997). The Leu-568→Ala,
Trp-571→Arg, and Asn-656→Leu mutations are particu-that this conformation of gp41 is found in the fusion-
active state of HIV envelope. larly noteworthy because cells expressing mutant enve-
lope glycoproteins with one of these point mutationsFirst, the N36/C34 complex folds in the absence of
gp120. The fusogenic state of gp41 is expected to be are completely defective in membrane fusion, as judged
by an inability to form syncytia with CD4-positive humanstable in the absence of gp120, since dissociation of
gp120 from the envelope glycoprotein is thought to ac- lymphocyte lines, even though the mutant proteins ex-
hibit substantial cell-surface expression, CD4 binding,company the conversion from a native to a fusogenic
state (Cohen, 1996; Wilkinson, 1996). Similarly, the con- gp120/gp41 association, gp160 precursor processing,
and soluble CD4-induced shedding (Cao et al., 1993).version of influenza HA2 to the fusogenic state is accom-
panied by loss of most of its contacts with HA1. Proteo- Leu-568 and Trp-571 are N36 residues that line the right
wall of the cavity shown in Figure 7 (right panel). Asn-lysis of the low-pH-converted form of HA prior to
crystallization removes most of the receptor-binding 656 is in an a position of the C34 peptide and packs
against the central N36 coiled-coil trimer. The locationsHA1 subunit (Bullough et al., 1994). Moreover, the struc-
tural features of the fusogenic state are preserved in of these key mutations suggest that interactions be-
tween the N36 and C34 helices are critical for membranefragments of HA2 that fold cooperatively in the complete
absence of the HA1 subunit (Carr and Kim, 1993; Chen fusion.
Fourth, our proposal that the N36/34 structure corre-et al., 1995b).
Second, the isolated gp41 core is exceedingly stable sponds to the core of the fusogenic state of gp41 is
Cell
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Figure 6. Conserved Grooves on the Surface
of the N36 Trimer
The C34 peptides, represented by blue rods,
are shown against a surface representation
of the N36 trimer. Residues on the surface of
the N36 trimer that are identical between HIV
and SIV are colored white, and nonidentical
residues are green. Note that the C34 helix
packs into a conserved (white) groove on the
surface of the trimer, while nonconserved
(green) regions of N36 are mostly surface-
exposed.
consistent with a large body of data on the inhibition of et al., 1995a). Further evidence in support of a dominant-
negative mechanism is provided by the finding that mu-HIV-1 infection and syncytia formation by derivatives
of the peptides that make up this core. This issue is tations in C-peptide derivatives that disrupt their interac-
tions with N peptide correlate with decreased potencydiscussed in more detail below.
Finally, the structural similarity of the N36/C34 com- as inhibitors (Wild et al., 1995).
The gp41 core crystal structure is fully consistent withplex to the low-pH-induced conformation of influenza
HA2 (Bullough et al., 1994) and to the structure of Mo- this dominant-negative mechanism of inhibition (Figures
3 and 6). The C-peptide derivatives could act as domi-MLV TM (Fass et al., 1996), each of which has been
proposed to represent fusion-active conformations, nant-negative inhibitors by binding to the endogenous
N-peptide coiled-coil trimerwithin viral gp41. The N pep-suggests that N36/C34 is the core of the fusogenic con-
formation of gp41. For all three structures, the hydropho- tides might inhibit fusion by interfering with formation
of the central, coiled-coil trimer within viral gp41 and/bic fusion peptide would be immediately amino terminal
to a central, three-stranded coiled coil. In influenza HA2 or by binding to endogenous viral C-peptide regions.
Both the N- and C-peptide classes of inhibitors areand HIV-1 gp41, the central three-stranded coiled coils
are each stabilized by three helices that pack obliquely effective against a wide range of HIV strains, including
laboratory-adapted strains and primary isolates (Wild etagainst the coiled-coil trimer in an antiparallel manner.
In the TM subunit of Mo-MLV, these obliquely packed al., 1992; Jiang et al., 1993; Wild et al., 1994b). In con-
trast, soluble CD4 and many neutralizing antibodies arehelices are replaced by a short helix and an extended
region that serve a similar structural role. typically effective only on a limited subset of HIV strains
(e.g., Nara et al., 1988; Palker et al., 1988; Daar et al.,
1990; Moore et al.,1995). There is a striking conservationInhibitors of HIV-1 Infection
Synthetic peptides containing approximately 40 resi- of residues involved in interactions between the N pep-
tide and C peptide, comparing gp41 from HIV-1 anddues from gp41 that overlap, or include all of, the resi-
dues in N36 or C34 can be effective inhibitors, at micro- SIV (Figure 6). We conclude that the broad neutralizing
effects of the N and C peptides derive from the strongmolar to nanomolar concentrations, of HIV infection and
syncytia formation (Wild et al., 1992, 1994b; Jiang et al., sequence conservation of these residues.
The highly conserved, deep cavities on the N-peptide1993; Lu et al., 1995). Our earlier investigation into the
inhibitory properties of the N51 and C43 peptides im- coiled-coil trimer that accommodate conserved C-pep-
tide residues are attractive targets for the developmentplied that these peptides work in a dominant-negative
manner (Herskowitz, 1987) by binding to viral gp41 (Lu of new peptidomimetic or small-molecule inhibitors of
HIV infection. The two indole rings and neighboring sideet al., 1995), a conclusion that was also reached through
studies of a gp41 ectodomain chimeric protein (Chen chains that occupy the prominent cavity depicted in
Crystal Structure of the HIV-1 gp41 Core
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Figure 7. Interaction of C34 Residues with a Large Cavity on the N36 Trimer Surface
(Left panel) A surface representation of the cavity in the carboxy-terminal portion of the N36 trimer, colored as in Figure 6. Residues in C34
that dock into this pocket are colored purple (Ile-635, Asp-632, Trp-631, and Trp-628). (Right panel) Residues that form the cavity in the N36
coiled-coil surface are labeled. A prime (9) is used to distinguish residues of one N36 helix from those of an adjacent N36 helix. This orientation
is rotated z308 to the left relative to the left panel, in order to facilitate visualization of all the side chains.
Figure 7 are a particularly attractive starting point for al., 1996). These common structural features suggest
that the rich body of work investigating the mechanismthe design and/or development of new drugs. Not only
is this cavity deep and highly conserved, but two of of membrane fusion for many other viruses, including
influenza, is relevant for understanding the mechanismthe three key mutations that disrupt membrane fusion,
discussed above, map to one wall of this cavity (Figure of HIV-mediated membrane fusion.
Given the similarity in structure between the HIV gp417). Because some of the known potent peptide inhibitors
(Wild et al., 1994b) extend beyond N36 and C34 and core and the low-pH-converted conformation of HA2, it
is worth considering whether the structural rearrange-do not involve this cavity region, it is likely that other
distinctive surface features exist in the interface be- ments that occur during the transition of HA2 to the
fusogenic state are analogous to those in gp41. In thetween the N and C helices of longer peptides such as
N51 and C43 (Lu et al., 1995). The importance of identi- native, nonfusogenic conformation of influenza HA, part
of the N-terminal coiled-coil trimer seen in the fusogenicfying drugs that target the HIV membrane-fusion ma-
chinery is emphasized by the success of combination state (Bullough et al., 1994) is held in a nonhelical, hairpin
structure, as a result of extensive interactions with thedrug regimens for the treatment of AIDS (review, Lipsky,
1996). As yet, these combination therapies do not target receptor-binding HA1 subunit (Wilson et al., 1981). Thus,
the receptor-binding HA1 subunit acts as a ªclampº thatthe HIV envelope.
binds this N-terminal region of HA2, holding it in the non-
coiled-coil conformation. The receptor-binding domainsImplications for gp41 Function and Viral
Membrane Fusion dissociate in the fusogenic conformation of HA, as in
HIV, although in the case of influenza, the HA1 subunitsThe structures of thecores of themembrane-fusion sub-
units from HIV, Mo-MLV, and influenza virus are remark- are still tethered via a disulfide bond to HA2. Upon re-
lease of the HA1 clamp, a dramatic conformationalably similar (Figure 8). It appears that these diverse vi-
ruses present fusion peptides to target cells via a change in HA2 occurs, including coiled-coil formation
by this N-terminal region (Carr and Kim, 1993; Bulloughcommon scaffold, in which the fusion peptides are atop
a central, three-stranded coiled coil that is supported et al., 1994).
A substantial conformational change in the envelopeby additional, carboxy-terminal structures. This scaffold
is likely to be a common feature of viral membrane- glycoprotein complex is also thought tobe criticalduring
HIV infection, though few details are understood. It re-fusion proteins since many of these proteins contain
coiled-coil signature sequences, with 4-3 heptad re- mains to be determined whether the HIV envelope com-
plex also utilizes coiled-coil formation as part of apeats of hydrophobic amino acids, adjacent to an
amino-terminal fusion-peptide region (Gallaher et al., spring-loaded mechanism, or if the gp41 core structure
determined here is present in the native as well as the1989; Chambers et al., 1990; Delwart et al., 1990). More-
over, studies of the fusion proteins of several paramyo- fusogenic state. It is possible that the N36/C34 structure
is the core structure of gp41 even when it is bound toviruses have identified regions with similarity to the N-
and C-peptide regions of HIV and SIV gp41 (Lambert et gp120, and that release of gp120 simply exposes the
Cell
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Figure 8. Comparison of Influenza HA2, HIV
gp41, and Mo-MLV TM Structures
The top panel shows an end-on view of the
three structures from the top, as in the left
panel of Figure 3. The bottom panel shows a
side view. The three monomers forming the
central coiled coil of each structure are col-
ored yellow, green, and blue. Supporting
structures are colored purple. Residues 40±
129 of HA2 (Bullough et al., 1994) and 45±98
of Mo-MLV TM (Fass et al., 1996) are in-
cluded. The figure was generated using the
program Insight (Biosym).
(X-stream), and data was collected on a Rigaku RU-200 rotating-fusion-peptide region of gp41. Alternatively, HIV gp120,
anode X-ray generator with an R-axis IIc detector.like influenza HA1, may serve as a clamp that represses
formation of the N36/C34 structure presented here, with Heavy Atom Screen and Phase Determination
gp120 shedding allowing its formation. This gp41 core Multiwavelength anomalous diffraction (MAD) data were collectedat
structure serves as the starting point for addressing the Howard Hughes Medical Institute beamline X4A of the National
Synchrotron Light Source at Brookhaven National Laboratory. Fluo-this and other essential structural questions about the
rescence spectra (1.1459±1.1354 AÊ ) were obtained from a singlemechanism of HIV entry into cells.
flash-frozen crystal soaked in 0.04% OsO4 in harvest buffer (80
mM NH4Cl, 20% PEG200, 30% isopropanol) for 4 hr. Based on theExperimental Procedures
fluorescence profile, individual data sets were collected on Fuji im-
aging plates at four wavelengths (l1 5 1.1396 AÊ , l2 5 1.1398 AÊ , l3 5Peptide Purification and Crystallization 1.1402 AÊ , and l4 5 1.1344 AÊ ). Reflections were integrated and scaledPeptides N36 and C34 were synthesized by standard FMOC peptide with DENZO and SCALEPACK (Otwinowski, 1993).
chemistry and have an acetylated N terminus and a C-terminal am- Data scaling, phase determination, and map generation were all
ide. N36 corresponds to residues 546±581 of gp160, while C34 corre- performed using the CCP4 suite of programs (CCP4, 1994). Anoma-
sponds to residues 628±661. After cleavage from the resin, the pep- lous and dispersive difference Patterson maps from MAD data sets
tides were desalted on a Sephadex G-25 column (Pharmacia) and all showed a single clear peak corresponding to the osmium binding
lyophilized. Peptides were then purified by reverse-phase high per- site. The position of the site was calculated from the single z 5 0
formance liquid chromatography (Waters, Inc.) on a Vydac C18 pre- Harker section and from cross-peaks found at z 5 0.28 and z 5
parative column. The identity of the peptides was verified by mass 0.71. Phases generated with the program MLPHARE (Otwinowski,
spectrometry. Peptide concentration was determined by tyrosine 1991) gave an overall figure of merit of 0.89 (Table 1) and produced
and tryptophan absorbance in 6 M GuHCl (Edelhoch, 1967). an interpretable electron density map with a clear solvent boundary.
To grow crystals, a 10 mg/ml stock of the N36/C34 complex was Density modification was subsequently performed using DM (Cow-
diluted 1:1 in a sitting drop with 80 mM NH4Cl, 20% PEG200, and tan, 1994), resulting in maps of high quality in which electron density
50% isopropanol and allowed to equilibrate against a reservoir of for the entire main chain and all side chains was evident (Figure 2).
80 mM NH4Cl, 20% PEG200, and 30% isopropanol. Crystals grew
as hexagonal prisms and belonged to the space group P321 (a 5 Model Refinement
b 5 49.5 AÊ , c 5 55.3 AÊ ). For native data sets andheavy atom screens, The polypeptide chain was traced and the side chains readily posi-
tioned into a 2.7 AÊ density-modified map using the program O (Jonescrystals were flash-frozen in a MSC cryogenic crystal cooler
Crystal Structure of the HIV-1 gp41 Core
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and Kjeldgaard, 1992). The initial model of N36/C34 was refined Chen, J., Wharton, S.A., Weissenhorn, W., Calder, L.J., Hughson,
F.M., Skehel, J.J., and Wiley, D.C. (1995b). A soluble domain of thewith the program XPLOR (BruÈ nger, 1992a) against data to 2.0 AÊ
from a native crystal. An anisotropic B-factor was applied to the membrane-anchoring chain of influenza virus hemagglutinin (HA2)
folds in Escherichia coli into the low-pH-induced conformation.native structure factors using XPLOR, and a free R set (BruÈ nger,
1992b) was taken from the data prior to refinement (Table 1). The Proc. Natl. Acad. Sci. USA 92, 12205±12209.
model was refined by iterative cycles of grouped B-factor, posi- Chen, S.S. (1994). Functional role of the zipper motif region of human
tional, and individual B-factor refinement. As the refinement pro- immunodeficiency virus type1 transmembrane protein gp41.J. Virol.
ceeded, 43 waters were added and a bulk solvent correction was 68, 2002±2010.
applied. At no time during the refinement did the molecule differ
Chen, S.S., Lee, C.N., Lee, W.R., McIntosh, K., and Lee, T.H. (1993).enough from the original model so as to require manual rebuilding,
Mutational analysis of the leucine zipper-like motif of the humanthough main chain and side chain geometries were optimized in O
immunodeficiency virus type 1 envelope transmembrane glycopro-between cycles of refinement. The quality of the structure was veri-
tein. J. Virol. 67, 3615±3619.fied by PROCHECK (Laskowski et al., 1993), with all residues but
one (Ile-580) occupying most-preferred regions of Ramachandran Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D.,
space. Ile-580 lies in the additionally allowed region of Ramachan- Wu, L., Mackay, C.R., LaRosa, G., Newman, W., Gerard, N., Gerard,
dran space and is the second residue from the C terminus of the C., and Sodroski, J. (1996). The beta-chemokine receptors CCR3
N36 peptide; inspection of the solvent-flattened MAD-phased maps and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85,
confirmed its position. Refined coordinates will be deposited in the 1135±1148.
Protein Data Bank (Brookhaven National Laboratory, Upton, NY). Cohen, C., and Parry, D.A. (1990). Alpha-helical coiled coils and
bundles: how to design an alpha-helical protein. Proteins 7, 1±15.
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